Ellis Investment Partners, LLC Pds Biotechnology Corp Transaction History

Ellis Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	BUY	$4.78 - $8.43 $2,868 - $5,058	600 Added 9.6%	6,850 $42,000
Q2 2021 Jul 26, 2021	SELL	$4.35 - $12.86 $6,524 - $19,290	-1,500 Reduced 19.35%	6,250 $78,000
Q1 2021 May 03, 2021	SELL	$2.28 - $6.81 $23,027 - $68,781	-10,100 Reduced 56.58%	7,750 $35,000
Q4 2020 Jan 20, 2021	BUY	$1.91 - $2.67 $29,796 - $41,652	15,600 Added 693.33%	17,850 $38,000
Q4 2019 Jan 07, 2020	SELL	$2.08 - $4.07 $2,080 - $4,070	-1,000 Reduced 30.77%	2,250 $5,000
Q2 2019 Jul 24, 2019	BUY	$5.44 - $8.68 $17,680 - $28,210	3,250 New	3,250 $19,000

4.22M

170K

6.7K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $36.1M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellis Investment Partners, LLC with notifications on news.